Clinical study on the efficacy and safety of extracorporeal blood oxygenation and ozonation in ischemic cardiovascular patients - EBOO in cardiologt

• Conditions: Patient with ischemic cardiopaty; Level: HLTClassification code 10011085

• Registration Number: EUCTR2006-001547-59-IT
• Lead Sponsor: AZIENDA OSPEDALIERA SENESE

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-04-18
• Last Update Posted: 27 January 2014

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Ischemic cardiopatic patients selected for surgery
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Acute ischemic syndrome 30 days before the study inclusion. Severe other cardiopaties. Diabetic patients

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: Evaluation of the effects of EBOO therapy in patients with ischemic cardiopaty;Secondary Objective: None;Primary end point(s): Improvement of the heart ischemia